✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Contraceptive Pills Market Research Report Information By Drug Class (Monophasic, Triphasic and Others), By Combination Pills (Monophasic and Multiphasic Pills), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032


ID: MRFR/Pharma/1586-HCR | 80 Pages | Author: Kinjoll Dey| November 2024

Contraceptive Pills Market Segmentation


Contraceptive Pills Drug Class Outlook (USD Billion, 2019-2030)




  • Monophasic




  • Triphasic




  • Others




Contraceptive Pills Combination Pills Outlook (USD Billion, 2019-2030)




  • Monophasic




  • Multiphasic Pills




Contraceptive Pills Regional Outlook (USD Billion, 2019-2030)




  • North America Outlook (USD Billion, 2019-2030)




    • North America Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • North America Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • US Outlook (USD Billion, 2019-2030)




    • US Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • US Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • CANADA Outlook (USD Billion, 2019-2030)




    • CANADA Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • CANADA Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills








  • Europe Outlook (USD Billion, 2019-2030)




    • Europe Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Europe Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • Germany Outlook (USD Billion, 2019-2030)




    • Germany Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Germany Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • France Outlook (USD Billion, 2019-2030)




    • France Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • France Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • UK Outlook (USD Billion, 2019-2030)




    • UK Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • UK Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • ITALY Outlook (USD Billion, 2019-2030)




    • ITALY Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • ITALY Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • SPAIN Outlook (USD Billion, 2019-2030)




    • Spain Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Spain Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • Rest Of Europe Outlook (USD Billion, 2019-2030)




    • Rest Of Europe Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • REST OF EUROPE Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills








  • Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Asia-Pacific Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Asia-Pacific Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • China Outlook (USD Billion, 2019-2030)




    • China Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • China Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • Japan Outlook (USD Billion, 2019-2030)




    • Japan Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Japan Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • India Outlook (USD Billion, 2019-2030)




    • India Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • India Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • Australia Outlook (USD Billion, 2019-2030)




    • Australia Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Australia Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Rest of Asia-Pacific Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Rest of Asia-Pacific Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills








  • Rest of the World Outlook (USD Billion, 2019-2030)




    • Rest of the World Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Rest of the World Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • Middle East Outlook (USD Billion, 2019-2030)




    • Middle East Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Middle East Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • Africa Outlook (USD Billion, 2019-2030)




    • Africa Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Africa Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills






    • Latin America Outlook (USD Billion, 2019-2030)




    • Latin America Contraceptive Pills by Drug Class




      • Monophasic




      • Triphasic




      • Others






    • Latin America Contraceptive Pills by Combination Pills




      • Monophasic




      • Multiphasic Pills







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5 GLOBAL CONTRACEPTIVE PILLS MARKET, BY DRUG CLASS

5.1 Monophasic

5.2 Triphasic

5.3 Others

GLOBAL CONTRACEPTIVE PILLS MARKET, BY REGION

6..1 AMERICA

6..1.1 INTRODUCTION

6..2 EUROPE

6..2.1 INTRODUCTION

6..3 ASIA-PACIFIC

6..3.1 INTRODUCTION

6..4 MIDDLE EAST & AFRICA

6..4.1 INTRODUCTION

7 COMPETITIVE LANDSCAPE

7.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

7.1.1 STRATEGIC PARTNERSHIP

7.1.2 MERGER & ACQUISITION

8 COMPANY PROFILE

8.1 ALLERGAN, PLC

8.1.1 OVERVIEW

8.1.2 PRODUCT OVERVIEW

8.1.3 FINANCIALS

8.1.4 KEY DEVELOPMENTS

8.2 Lupin Pharmaceuticals, Inc

8.2.1 OVERVIEW

8.2.2 PRODUCT OVERVIEW

8.2.3 FINANCIALS

8.2.4 KEY DEVELOPMENTS

8.3 Mankind Pharma

8.3.1 OVERVIEW

8.3.2 PRODUCT OVERVIEW

8.3.3 FINANCIALS

8.3.4 KEY DEVELOPMENT

8.4 Teva pharmaceuticals

8.4.1 OVERVIEW

8.4.2 PRODUCT OVERVIEW

8.4.3 FINANCIALS

8.4.4 KEY DEVELOPMENTS

8.5 Syzygy Healthcare

8.5.1 OVERVIEW

8.5.2 PRODUCT OVERVIEW

8.5.3 FINANCIALS

8.5.4 KEY DEVELOPMENTS

8.6 OTHERS

List of Tables

TABLE 1 GLOBAL CONTRACEPTIVE PILLS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 2 GLOBAL CONTRACEPTIVE PILLS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL CONTRACEPTIVE PILLS MARKET, BY REGION, 2020-2027 (USD MILLION)

List of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL CONTRACEPTIVE PILLS MARKET, BY TYPE

FIGURE 4 GLOBAL CONTRACEPTIVE PILLS MARKET, BY END USER

FIGURE 5 GLOBAL CONTRACEPTIVE PILLS MARKET, BY REGION

FIGURE 6 GLOBAL CONTRACEPTIVE PILLS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
Contraceptive Drugs Market Research Report - Global Forecast till 2032
Press Release
pr-img
Global Contraceptive pills Market Projected to Grow Radiantly By 2032; asserts MRFR Unleashing In...
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)